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Abstract
Mutations in the tumor suppressor gene PTEN (MMAC1/TEP1) are associated with a large number of
human cancers and several autosomal-dominant disorders. Mice mutant for PTEN die at early
embryonic stages and the mutant embryonic fibroblasts display decreased sensitivity to cell death.
Overexpression of PTEN in different mammalian tissue culture cells affects various processes including
cell proliferation, cell death and cell migration. We have characterized the Drosophila PTEN gene and
present evidence that both inactivation and overexpression of PTEN affect cell size, while
overexpression of PTEN also inhibits cell cycle progression at early mitosis and promotes cell death
during eye development in a context-dependent manner. Furthermore, we have shown that PTEN acts in
the insulin signaling pathway and all signals from the insulin receptor can be antagonized by either
Drosophila or human PTEN, suggesting a potential means for alleviating symptoms associated with
altered insulin signaling.
INTRODUCTION
The tumor suppressor gene PTEN is one of the most frequently
mutated genes involved in the development of human cancer
(Cantley and Neel, 1999; Li et al., 1997a; Steck et al., 1997).
PTEN mutations are found in a wide variety of tumors such as
glioblastomas, endometrial carcinomas, advanced prostate
cancers and melanoma cells (Cairns et al., 1997; Guldberg et
al., 1997; Li et al., 1997a; Liu et al., 1997; Rasheed et al., 1997;
Risinger et al., 1997; Tashiro et al., 1997; Wang et al., 1997).
Germ-line mutations in PTEN are linked to three rare
autosomal dominant syndromes: Cowden Disease, Bannayan-
Zonana syndrome and Lhermitte-Duclose disease (Liaw et al.,
1997; Marsh et al., 1997). A common feature of these
syndromes is a predisposition for the development of
hamartomas, benign tumors that have differentiated but
disorganized cells. 
The PTEN protein contains the phosphatase signature motif
HCXXGXXRS/T that is found in all protein tyrosine
phosphatases (Denu et al., 1996; Li and Sun, 1997; Li et al.,
1997a; Steck et al., 1997). This phosphatase domain is the most
common site of germline or sporadic PTEN mutations (Myers
and Tonks, 1997). In vitro studies have demonstrated that
PTEN can dephosphorylate phosphotyrosine, phosphoserine
and phosphothreonine residues on artificial substrates (Li and
Sun, 1997; Myers et al., 1997). Recently, PTEN has been
shown to have strong in vitro and in vivo activity for the 3¢
position of phosphatidyl inositol 3,4,5 trisphosphate (PIP3)
(Maehama and Dixon, 1998). PIP3 is produced by the catalytic
activity of phosphatidyl inositol 3 kinase (PI3K) and can act
as a membrane-embedded second messenger for the activation
of a variety of signaling molecules. 
A number of Pten mutant mice have been described (Di
Cristofano et al., 1998; Podsypanina et al., 1999; Suzuki et al.,
1998). Although the spectrum of disorders affecting the Pten
mutant mice varies between the different strains, all
homozygous Pten mutants exhibit early embryonic lethality
(E7.5-E9.5) and the heterozygotes display a predisposition to
tumor development (Di Cristofano et al., 1998; Podsypanina et
al., 1999; Suzuki et al., 1998). Consistent with the role for
PTEN as a PIP3 phosphatase, Pten mutant cells exhibit
increased PIP3 signaling (Stambolic et al., 1998; Sun et al.,
1999). 
The C. elegans gene daf-18 encodes a distant PTEN
homolog (Gil et al., 1999; Mihaylova et al., 1999; Ogg and
Ruvkun, 1998; Rouault et al., 1999). In addition to a conserved
phosphatase domain, daf-18 encodes a large non-homologous
C-terminal region (Ogg and Ruvkun, 1998). Daf-18 mutants
can suppress the mutant phenotypes of daf-2, the C. elegans
insulin-like receptor, and age-1, the C. elegans PI3K (Gil et al.,
1999; Mihaylova et al., 1999; Ogg and Ruvkun, 1998; Rouault
et al., 1999). 
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Mutations in the tumor suppressor gene PTEN
(MMAC1/TEP1) are associated with a large number of
human cancers and several autosomal-dominant disorders.
Mice mutant for PTEN die at early embryonic stages and
the mutant embryonic fibroblasts display decreased
sensitivity to cell death. Overexpression of PTEN in
different mammalian tissue culture cells affects various
processes including cell proliferation, cell death and cell
migration. We have characterized the Drosophila PTEN
gene and present evidence that both inactivation
and overexpression of PTEN affect cell size, while
overexpression of PTEN also inhibits cell cycle progression
at early mitosis and promotes cell death during eye
development in a context-dependent manner. Furthermore,
we have shown that PTEN acts in the insulin signaling
pathway and all signals from the insulin receptor can be
antagonized by either Drosophila or human PTEN,
suggesting a potential means for alleviating symptoms
associated with altered insulin signaling.
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A variety of cellular functions have been reported for PTEN
using different mammalian systems. Overexpression of PTEN
in PTEN- glioblastoma cells inhibits cell cycle progression
(Cheney et al., 1998; Furnari et al., 1997). Furthermore,
homozygous Pten mutant mice exhibit regions of increased cell
proliferation (Suzuki et al., 1998). These results suggest a role
for PTEN in regulating cell division. On the other hand,
overexpression of PTEN in PTEN- breast and prostate cancer
cells causes apoptosis (Li et al., 1998; Myers et al., 1998), and
immortalized Pten mutant fibroblasts exhibit an elevated
resistance to apoptosis (Stambolic et al., 1998). Thus, PTEN
could have a distinct role in regulating apoptosis. Furthermore,
PTEN has been reported to inhibit cell migration by directly
dephosphorylating focal adhesion kinase (FAK) and Shc (Gu
et al., 1999; Tamura et al., 1998). In C. elegans, daf-18 has
been shown to be involved in dauer formation (Gil et al., 1999;
Mihaylova et al., 1999; Ogg and Ruvkun, 1998; Rouault et al.,
1999).
To explore the various roles of PTEN during development,
we have isolated and characterized the Drosophila PTEN
homolog. We show that fly PTEN functions in the insulin
signaling pathway, and both human and fly PTEN elicit similar
effects during Drosophila eye development. Using this
Drosophila system, we demonstrate that PTEN affects cell
proliferation and apoptosis in a developmental context-
dependent manner. Furthermore, we show that PTEN plays an
essential in the regulation of cell size. 
MATERIALS AND METHODS
Molecular biology
The low stringency condition used in cDNA library screening was as
described (Tao et al., 1999). Three dPTEN cDNA were isolated and
sequenced. A 1.8 kb dPTEN cDNA, a wild-type human PTEN cDNA
and the human PTENC124S mutant cDNA were cloned into pUAST
for P-transformation (Brand and Perrimon, 1993). The dPTEN
genomic region was isolated from P1 clones Ds01978, Ds02806 and
Ds05299 (Berkeley Drosophila Genome Project). A 6.2 kb SpeI
genomic fragment was cloned into pW8 for rescue experiments. 
Fly genetics
dPTENc494 is an EMS-induced mutation isolated from a screen for
lines that failed to complement the Df(2L) J1 b1 Tft1 deficiency.
Clones of dPTEN mutant cells were generated by X-ray irradiation of
w; P[w+; ry+] 30C P[ry+; hs-neo; FRT] 40A/ dPTENc494 larvae (Xu
and Harrison, 1994). Multiple lines for each P-element construct were
established. At least three independent lines carrying UAS-PTEN and
UAS-dPTEN were tested for each GAL4 cross and they all gave similar
phenotype. As controls, five lines carrying UAS-PTENC124S or GAL4
lines alone were treated in parallel. Dp110DN was originally called
Dp110D954A (Leevers et al., 1996). UAS-p21, GMR-GAL4 and EYE-
GAL4 were gifts from I. Hariharan, M. Freeman and W. Gehring. 
Flow cytometry
Eye discs from wandering third instar larvae were dissected in PBS
and dissociated in PBS with 5 mg/ml porcine trypsin (Intergen) and
1 mM EDTA at room temperature for 2 hours. Dissociated cells were
washed 3 times, resuspended in 200 m l of cold PBS containing 6 mM
EDTA, and fixed by six stepwise additions of 100 m l each of cold 95%
ethanol. After staining with propidium iodide, the cell cycle profiles
were determined using a Becton Dickinson FACS Vantage, and the
data was analyzed using the Modify 5.2 model (Verity Software
House). Approximately 200-250 discs for each genotype were
dissociated, and at least 15,000 cells were analyzed for each sample.
We found no difference between human and fly PTEN transgenes
tested. 
Histology and immunofluorescence
Eye disc fixing and staining, scanning electron microscopy (SEM) and
adult eye sections were performed as described (Xu and Harrison,
1994). Acridine orange staining was performed according to Spreij
(1971). For labeling of cells in S phase, eye discs were dissected in
PBS solution, incubated in M3 solution (Sigma) containing 500 m g/ml
BrdU (Sigma) for 60 minutes at room temperature, and fixed in 4%
paraformaldehyde in PBST (PBS with 0.3% Triton X-100) for 30
minutes at room temperature. Signals were detected with anti-BrdU
antibody (1:50, Becton Dickinson). Samples were collected using
confocal microscopy (BioRad, MRC-1024).
RESULTS AND DISCUSSION
Isolation and characterization of the Drosophila
PTEN gene
We have identified a Drosophila PTEN (dPTEN) homolog by
screening an imaginal disc cDNA library using a human PTEN
probe at low stringency (Materials and Methods; Fig. 1). The
fly and human PTEN gene products are similar in length and
share sequence similarities in both the N-terminal phosphatase
domain and the C-terminal region (overall 44% amino acids
(aa) identical; Fig. 1B). We determined the genomic
organization for dPTEN and mapped the gene to the cytological
region 31C-D (Fig. 1A). To isolate mutations in dPTEN, we
carried out a genetic screen and isolated ten lethal
complementation groups using the Df(2) J1 deficiency, which
removes dPTEN as well as other genes (Fig. 1A). The lethality
of one group consisting of a single allele (dPTENc494) can be
fully rescued by P-element transformants carrying dPTEN
genomic DNA (Fig. 1A). Two lines of evidence indicate that
this mutation is a null or strong dPTEN allele. First, sequence
analysis reveals a G135E change in the coding region (Fig.
1B). This is an invariant residue in the active-site motif of the
catalytic domain and is required for phosphatase activity (Denu
and Dixon, 1998). Indeed, an identical change in human PTEN
has been previously found in human melanomas (Guldberg et
al., 1997). Moreover, both dPTENc494 homozygotes and
dPTENc494/Df(2)J1 trans-heterozygotes die at a similar late
embryonic/early first instar larval stage. Thus, dPTEN encodes
a vital function that is needed for Drosophila early
development.
Loss of dPTEN affects cell size but not patterning
during eye development
To gain insight into the functions of dPTEN during
development, we examined clones of cells that lack dPTEN in
the Drosophila eye. The compound eye provides a useful
model for studying cell proliferation and differentiation and yet
it is dispensable for viability. dPTENc494 mutant ommatidia in
the mosaic eyes appear larger in size compared to their
neighboring wild-type ommatidia (Fig. 2A). Sections of these
mosaic eyes revealed that the mutant ommatidia have normal
photoreceptor cell composition and orientation (Fig. 2B,D).
However, the sizes of the individual mutant cells are much
larger than their neighboring wild-type cells (the average size
of a mutant ommatidium is approximately 2.5 times of that of
H. Huang and others
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a wild-type one; Fig. 2B-D). Careful examination of the
chimeric ommatidia that contain both mutant and wild-type
cells revealed that the PTEN mutant phenotype is cell
autonomous, as every mutant cell has an enlarged cell body
while its immediate wild-type neighbors have normal cell body
sizes (Fig. 2C). Unlike the Drosophila tumor suppressor genes
such as lats that we have previously analyzed (Tao et al., 1999;
Theodosiou et al., 1998; Xu et al., 1995), we did not observe
an obvious overproliferation defect in PTEN mutant clones in
the eye. This could be because dPTEN may not normally
K
K
E
G EPRKC DG L NGGHF E Y VD K TQP Y I GD DT S I GR NGMRRN ET PM K I D T GNF ESPWQ VN P P
P
V
VG
G
K
KS
S
S
S
V
V I
IK
K
P
GV
V
D
D
EKDKIYNE L
S
E E
A
F
F
F
T
D
V I
- - - -
H TI
E R L
E
NEVK D K E F I
DS I C S - - - - - - - - - - - - - - - - - - - -
DDVH S EH R F S E K S I F AE
EN
Y
E E
R
P- - GP E TS
N Y S C E SDG
K V - - G
T VNK I H
S L CDQ E I
T L SKS E I
- - - - - - - I E
N F S D VQ A
R
A
EA S S V P
TF
DY T
D
H
K
PKY
EK
C
D
NLEF
F Y
RRDPD
VEN
EEFESE
R
RDPVSAE
K H F T N E
- - - T KT V P S
ST NS KNT S T A C
NP S S TS T P DVS D NE HY -
R KQPN SKT L L P SL N D ST KE E I K
-
- - - - - - - - - - - - - - - - - -
N I N QP S I K K D L I KWQ
- -
S
F
YE R
P
KYC
N
LEF
TD ND K EYL V L
K E NEN L N
L T KN D L D KA KD -
RS D YD S SPN
K N R YF S - - - - -
AE K VL T A I V NDN
- - - - - - - - - - - - - N K V K L YF
T T KSQT I E T L DH KD I V T K IQ
280
288
T
D
Y                E
E
S
E Q
Y L
N P F - - - - - - - D E
P K FNCGT E DG E
D -QH T I TKV
DWESGE S T
- -
SD T
-
- - - - - - - - - YS T TD S D P
RS I N EN KN I N YNS I C KQ S
A
S
310
349
- -
T
350 hPTEN
dPTEN
DAF-18
409
375
469
I
NM DRA L K SK DL N GMKL HV VL RC VD T R DSKMMV EK SG D I RG GP E I P YK AE E H V L T F P Y
Q Y L
359
480
EKS EV F GNL A F HN T RL Q A QMNP KWRP EP C A F G SK GA EMHY P PSVRY SS ND GK YN G540
ACS EN L V SD F H R N I A V R Y RY F Y KQRS T S RS R PR F RY C L I KK HF YI PA DT DD V600 DAF-18
DEN GQPF H SP EH I KE QE K I A EK AA GI NT GP ST SGSS AP GT I K T Q D K K A660 DAF-18
T E EL P AR L P N V F PV VGVD F E NP EE ES CE HK T V ES I A GF EP L E L H ES YH PN A G720 DAF-18
NML RQDY HT DS V L K I A EQEA KA F V DQL L NGQGVL QE F MKQF K VP SD NS F A V GQA780 DAF-18
VF KA QI AL L E Q D QRV QA NA VD L E HT L GEA F E RF GH VV EE SN GS SK NP KA L K T R E840 DAF-18
QMVKE T GKD T QKT RN HV L L HL EA NH RV QI ER RE T C PE L H PE DK I P RI AH F S EN SF S SN F900 DAF-18
D A I960 DAF-18
HYD T AK F NC R V AQYP F E DHNP P Q L E L I KP FC ED L QWL S EDD N HV A A I HCK AGKGR TGVM75
S YD VAK F R R V A VYP F DDHNP P T I E L I QR FC SD V MWL K ED S S N V V A HCK AGKGR TG TM83
Y YD ADN F D NV I C FD MT DH HP P S L E L MAP FC RE AK EWL EA DD K HV I A HCK AGKGR TGVM120
I C AY L L HR GKF L K AQ EA L D F Y GE VR TR DK KGVT I P SQRR Y V Y YY SY L L KNH L DYR PV AL L135
I C AY L VF S G I K K AD EA L AWY DE KR T K DR KGVT I P SQRR Y V QY F S L VCSS VP Y S KV SL N143
I C A L L I Y I N FY P PRQ I L D Y Y S I I R T K NN KGVT I P SQRR Y I Y YY H L RERE L NY L PL RM Q180
F HK MM F E T I PMF SGG T C NP QF V V CQL K VK I Y SS NS GP T R R E DKF - - MYF - - - - - - - - - E F195
VCE I R F- - - - - - S ES SC VQN L GM VE C I S VL HD SA T E NA P DRL K T L P I - - - - - - - - - D F203
L I G VY V ERP P K TWGGGS K I K VE V GNG T I L F KP DP L I I S S NHQR ER AT WL NN CD T P N E F240
PQP - - - - - - - - - - - - - - L- - - - - - - - P VCGD I K VE F F H K Q - N K ML KK D K MF HF WV NT F F244
QKS - - - - - - - - - - - - - - V L T I K PS I P V SGD K F E L T K K S - P D I - - - - C HF WL NT F F248
DT GEQKY HGF V SK RA YC MVP ED AP V F VE GD R I D I R E I GF L K FSD GK GHVWF NT MF A300
I
V
-
GL E K H I T E EQAM TN YGM I P RY T I SK I H EKH E KG V D YN DR K L PMG D SYT S G420
hPTEN
dPTEN
DAF-18
hPTEN
dPTEN
DAF-18
hPTEN
dPTEN
DAF-18
hPTEN
dPTEN
DAF-18
hPTEN
dPTEN
DAF-18
hPTEN
dPTEN
DAF-18
hPTEN
dPTEN
DAF-18
E
R
R R
R
Y
YD
D
F
F
M
M
MAN T
T A I I KE I VS R NKRRY1
I S L SN V I NV VS KK I RY1
VT PP PD VP ST ST RS MA RD L QEN PN RQPGEP RV SE PY H N S I VE R I RH I F T A VS S N CR T1
QEDGF DL D L T Y I Y PN I I AMGF PA - E R L EGVY RN NI D D VVR F L DSK H - KNHY K I Y N LC AER17
K EK GY DL D L T Y I N N I I AMG PA PDK L EGL RNRL E D VF K L L EEN H - AQHY K I Y N LC SER24
E YQ N I DL DC A Y I T R I I A I G PA TG - I E AN RN SKVQT QQF L T RR HGKGN V KVF N LR GGY61
M
hPTEN
dPTEN
DAF-18
hPTEN
dPTEN
DAF-18
Bg
Df(2L) J1
BSSSBSBgSSBBgBg
1 kb
Rox21
pW8-PTEN
PTEN LD31953 DROR basket chico
2 3 4 5 6 7 8 9 10 111
A
B
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function in the eye in regulating cell proliferation,
or alternatively, there may be redundancy for
PTEN-like molecules in the eye.
Overexpression of PTEN inhibits cell
proliferation during eye development
To explore other potential roles of dPTEN during
eye development, we used the UAS/GAL4 system
to overexpress both human and fly PTEN in
Drosophila (Brand and Perrimon, 1993).
Interestingly, the phenotypes caused by overexpression of
human PTEN and dPTEN are indistinguishable, suggesting
that the functions of the two homologs are conserved. For
simplicity, we will use the name PTEN in text while specifying
between human PTEN and dPTEN in figures when it is
necessary. To verify whether the effects that we observed with
expression of PTEN are related to its enzymatic activity, we
also tested a construct, UAS-PTENC124S, in which a critical
residue in the phosphatase domain has been mutated. This
change also leads to elimination of catalytic activity in vitro
(Li and Sun, 1997; Li et al., 1997b). While ectopic expression
of wild-type PTEN causes specific phenotypes (see below),
expression of PTENC124S under the same conditions has no
effect. Together with the PTENc494 mutant, these experiments
demonstrate that phosphatase activity is necessary for PTEN to
exert its functions during development.
Since ubiquitous expression of PTEN directed by heat-shock
induction of GAL4 causes lethality during embryonic and
larval stages, we expressed PTEN specifically in the
developing eye using the eyeless GAL4 line (EYE-GAL4). The
eyeless enhancer directs gene expression in the young
developing eye disc where cells are actively proliferating
H. Huang and others
Fig. 2. PTEN loss-of-function mutant phenotype in the
eye. (A) An adult mosaic eye containing a dPTENc494
clone (black shadow area, big arrow) with ommatidia
larger than neighboring wild-type ommatidia (small
arrow). (B-D) Cross sections of the same eye. Sections
revealed enlarged dPTEN mutant ommatidia (B) and
their photoreceptor cells (C,D). (C) Mutant cells (*) in a
chimeric ommatidium have enlarged bodies whereas a
wild-type cell in a chimeric ommatidium (arrow) has a
normal body size as indicated by the distance between
rhobdomere and pigment cells. (D) In non-apical
sections, vacuole-like structures are often located near
the rhabdomeres of dPTEN mutant ommatidia (arrow). 
Fig. 3. PTEN overexpression eye
phenotypes. Scanning electron
micrographs (SEMs) (A-D,I) and
tangential sections through adult
eyes (E-H) are shown. While
overexpression of wild-type PTEN
leads to smaller, flattened adult
eyes (B-C) or even no eyes (D),
overexpression of a mutant PTEN
with the inactive phosphatase
domain has no effect (I). In the
cross section of GMR-GAL4,
UAS-PTEN/UAS-PTEN (F),
photoreceptor cells have enlarged
and irregular shaped cell bodies.
Some pigment cells are missing
(F, arrowhead). (A,E,H) wild-type.
(B,F,G) GMR-GAL4/+; UAS-
dPTEN/UAS-dPTEN. (C,D) EYE-
GAL4/+; UAS-PTEN/UAS-PTEN.
(I) EYE-GAL4/UAS-PTENC124S;
UAS-PTENC124S/+.
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(Halder et al., 1998). Overexpression of PTEN in proliferating
cells of the eye disc resulted in dramatic reduction of eye sizes
in a dosage-dependent manner (Fig. 3C). In fact, multiple
copies of UAS-PTEN can completely eliminate the eye (Fig.
3D). This small adult eye phenotype could be caused either by
the inhibition of cell proliferation by PTEN, which would result
in eye discs of smaller than normal size, or by the failure of
ommatidium differentiation in eye discs of normal size. The
sizes of eye discs dissected from third instar larvae carrying
EYE-GAL4/UAS-PTEN were dramatically reduced (Fig.
4C,H), suggesting a defect in cell proliferation. Consistent with
Fig. 5. Overexpression of PTEN causes cell death in the
differentiating cells of the eye disc. Anti-Elav staining shows that the
pattern of photoreceptor differentiation in dPTEN-expressing third
instar eye disc (B) is comparable to that of a wild-type disc (A).
Acridine orange staining shows few apoptotic cells in a wild-type eye
disc (C) and massive cell death in the posterior region of the dPTEN-
expressing disc (D). The GMR-GAL4/UAS-dPTEN adult eye
phenotype can be largely rescued by coexpression of p35. The slight
disorganization of the eye in (F) is also seen in flies with GMR-p35
alone (Hay et al., 1994). Arrowheads indicate the MF, and anterior is
to the left. Similar results were obtained with human PTEN (data not
shown). (A,C) Wild type. (B,D) GMR-GAL4/+; UAS-dPTEN/UAS-
dPTEN. (E) GMR-GAL4/+; UAS-dPTEN/+. (F) GMR-GAL4/+;
UAS-dPTEN/UAS-p35.
Fig. 4. Overexpression of PTEN affects cell-cycle progression in
proliferating cells. While the BrdU-staining patterns are
indistinguishable between wild-type and GMR/dPTEN discs (A,D), the
number of staining cells are reduced in the anterior region of the
EYE/dPTEN third instar eye disc (C). BrdU incorporation is abolished
in the GMR/p21 disc posterior to the MF (B). Arrows indicate the MF,
and anterior is to the left. Confocal images of third instar eye discs
stained with anti-Elav antibody showing that neural differentiation is
relatively normal in PTEN-overexpressed small third instar eye disc
(H). (F,G) Propidium iodide staining shows that in a wild-type eye disc
few post-replication cells with bright nuclear staining can be seen
along regions anterior and posterior to the MF (G is an enlarged image
of the boxed region in F). (I,J) The anterior region of a EYE/PTEN-
expressing disc accumulates many bright staining cells with a DNA
content of 4C (arrow in J, which is an enlarged region of the boxed
image in I)). Histograms of FACS analysis display DNA content and
cell numbers (K,L). Similar results were obtained from three repeated
experiments. (A, E-G,K) wild type. (C,H-J,L) EYE-GAL4/+, UAS-
dPTEN/UAS-dPTEN. (B) GMR-GAL4/UAS-p21. (D) GMR-GAL4/+,
UAS-dPTEN/UAS-dPTEN.
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this idea, sections of these small adult eyes showed that all
types of photoreceptor cells were present and the pigment
lattice was essentially regular (data not shown), indicating that
cell differentiation and pattern formation are not disrupted.
Moreover, although these eye discs were much smaller, neural
differentiation in the posterior region occurs normally as
indicated by neuronal-specific anti-Elav staining (Fig. 4H)
(Robinow and White, 1991).
Overexpression of PTEN does not block G1/S
transition in the developing eye disc
Suppression of cell proliferation in mammalian tissue culture
cells by PTEN has been reported to act through blocking cell
cycle progression in the G1 phase (Furnari et al., 1998; Li and
Sun, 1998). To determine whether PTEN blocks G1/S
transition in the developing eye, we examined eye discs with
GMR-GAL4 driven PTEN expression. The GMR promoter
directs gene expression in the region posterior to the
morphogenetic furrow (MF) in the eye imaginal disc (Hay et
al., 1994). While most cells in this region are differentiating,
a stripe of cells posterior to MF undergo a synchronized, last
round of cell division. It has been previously shown that
GMR-directed expression of p21C1P1/WAF1, a human cyclin-
dependent kinase inhibitor, blocks this last round of division
by preventing these cells from entering S phase (de Nooij and
Hariharan, 1995) (Fig. 4B). Unlike the GMR-directed p21
expression, BrdU labeling showed that these PTEN-
expressing discs have the characteristic stripe of staining
similar to that of the wild-type discs (Fig. 4A,D), suggesting
that expression of PTEN does not block G1/S transition. In
contrast, propidium iodide staining of the EYE-GAL4/UAS-
PTEN eye discs revealed that the discs accumulate many cells
with brighter nuclear staining consistent with a DNA content
of 4C (Fig. 4I,J). FACS analysis of dissociated cells from these
discs also showed an increased percentage of cells in G2 (Fig.
4K,L) (Neufeld et al., 1998). These results suggest that
overexpression of PTEN during eye development causes cell
cycle arrest at the G2 or G2/M phase. 
Overexpression of PTEN in differentiating cells
triggers apoptosis
Overexpression of PTEN under the direction of GMR results
in adult eyes that are not only smaller but also rough (Fig. 3B).
Sections of these adult eyes revealed a complex phenotype with
varied degrees of severity. While the apical lenses of the
ommatidia are smaller (Fig. 3B), the sizes of photoreceptor
cells in the cross sections are larger than normal (Fig. 3F,G).
Furthermore, these GMR/PTEN adult eyes have a flattened
appearance with a narrowed retina (Fig. 3A,B; data not shown),
suggesting the mutant phenotype could result from changes in
both cell shape and size. In addition, different from the
phenotype caused by inactivation of PTEN, the rhobdomeres
of the PTEN-overexpressed photoreceptors are reduced in size
(Fig. 3G). Moreover, these sections showed that some
ommatidia had missing pigment or photoreceptor cells (Fig.
3F; data not shown). We therefore stained third instar eye discs
with the anti-Elav antibody to monitor retinal neuron
differentiation (Robinow and White, 1991). Elav staining
revealed a neuronal differentiation pattern comparable to wild
type (Fig. 5B), indicating that photoreceptor differentiation is
not affected. To pinpoint the cause of the phenotype, we further
assessed whether cell death might have contributed to the
GMR-GAL4/UAS-PTEN eye phenotype by staining these eye
discs with acridine orange. Unlike wild-type third instar eye
discs which have few dying cells (Wolff and Ready, 1991), the
GMR-GAL4/UAS-PTEN eye discs have a substantially
increased amount of cell death in the posterior region of the
eye disc, where GMR-GAL4 is expressed (Fig. 5D). To further
verify the contribution of cell death to the eye phenotype,
GMR-GAL4 was used to coexpress PTEN with the p35
baculovirus gene, which can block apoptotic cell death (Hay
et al., 1994; White et al., 1996). The eye phenotype induced
by GMR/PTEN was largely rescued by coexpression of p35
(Fig. 5F). 
These experiments suggested the possibility that cell death
might also contribute to the EYE/PTEN small eye phenotype.
However, we found that EYE/PTEN eye discs do not have
increased acridine orange staining and that the EYE/PTEN
small eye phenotype was not suppressed by coexpression of
p35 (data not shown). Thus, cell death appears not to be a major
factor in PTEN-mediated inhibition of cell proliferation.
Instead, these results suggest that cell death is a consequence
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Fig. 6. Genetic interactions of PTEN with genes involved in insulin
signaling. SEMs (A-F) are shown. (A) Expression of PTEN is dose-
sensitive; one copy of a EYE/PTEN transgene causes a moderately
reduced eye phenotype. (B) Coexpression of a wild-type D-PI3K
(Dp110) suppresses the eye phenotype caused by EYE/PTEN.
(C) Coexpression of a dominant-negative D-PI3K enhances the
EYE/PTEN eye phenotype. (D) Removing one copy of chico also
enhances the EYE/PTEN eye phenotype. (E) At 20-22°C,
overexpression of Inr with EYE-GAL4 results in a hyperplastic
growth eye phenotype. (F) Coexpression of EYE/PTEN suppresses
the Inr eye phenotype and, in turn, the EYE/PTEN eye phenotype is
suppressed by overexpression of Inr. Similar interactions were
observed when the human PTEN transgenes were tested (data not
shown). (A) EYE-GAL4, UAS-dPTEN/+. (B) EYE-GAL4, UAS-
dPTEN/UAS-Dp110wt. (C) EYE-GAL4, UAS-dPTEN/+; UAS-
Dp110DN/+. (D) EYE-GAL4, UAS-dPTEN/chico1. (E) EYE-
GAL4/UAS-Inrwt. (F) EYE-GAL4, UAS-dPTEN/UAS-Inrwt.
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of cells at different developmental stages in response to the
PTEN product. 
PTEN negatively regulates insulin signaling in
Drosophila
We have further examined the relationship between PTEN and
the Drosophila PI3 kinase (D-PI3K) gene, Dp110 (Leevers
et al., 1996). At 25°C, flies do not survive to adult when
wild-type D-PI3K is expressed with EYE-GAL4. Interestingly,
this lethality can be rescued by coexpression of PTEN.
Furthermore, the small eye phenotype of PTEN overexpression
is suppressed by overexpression of wild-type D-PI3K and
enhanced by overexpression of dominant negative D-PI3K
(Fig. 6A,B). These results clearly indicate that PTEN and PI3K
function antagonistically in Drosophila. 
The recent characterization of chico, a Drosophila IRS1-4
homolog, showed that chico, D-PI3K and insulin receptor (Inr)
act as positive elements in a Drosophila insulin signaling
pathway to regulate cell proliferation and cell size (Bohni et
al., 1999). Consistent with the role of PTEN as a negative
regulator in this insulin pathway, removal of one copy of the
chico gene genetically enhances the EYE/PTEN eye phenotype
(Fig. 6D). Overexpression of Inr (EYE/Inr) causes lethality at
25°C. At room temperature, few animals survive with
overproliferated eyes (Fig. 6E). Strikingly, cooverexpression of
PTEN completely rescues lethality and the overproliferation
phenotype (Fig. 6F). This suggests that all signals from the
insulin receptor can be antagonized by PTEN function.
Together with the previous findings that mammalian and C.
elegans PTEN molecules interact with components of the
insulin pathway (Furnari et al., 1998; Maehama and Dixon,
1998; Myers et al., 1998; Ogg and Ruvkun, 1998; Stambolic
et al., 1998; Sun et al., 1999), our genetic data argues that
PTEN functions as a major conserved negative regulator in the
insulin signaling pathway. 
The role of PTEN in tumor suppression is not fully
understood. Results from experiments involving different
mammalian cell systems favor different theories. In this study,
we have taken a genetic approach to analyze PTEN’s function
in Drosophila. Sequence analysis has shown that Drosophila
PTEN is a close homolog of human PTEN, sharing high
sequence similarity in both the N-terminal phosphatase domain
and in the C-terminal region. Furthermore, expressing human
and fly PTEN in Drosophila elicits similar effects during
development. These results indicate that Drosophila is a useful
model for studying PTEN functions. Phenotypes caused by
overexpression of PTEN depend on the developmental status
of the cells: overexpression of PTEN arrests cell-cycle
progression in proliferating cells while promoting apoptosis in
differentiating cells during eye development. These results
suggest that PTEN may suppress tumorigenesis by preventing
damaged cells from dividing and/or promoting a response to
apoptotic signals in a cell context-dependent manner. Although
it has been reported that PTEN affects cell migration in
mammalian cell cultures (Tamura et al., 1998), we did not
observe effects of PTEN on cell migration in Drosophila (H.
H. and T. X., unpublished data). In addition to previously
reported effects, we have shown for the first time that PTEN
function is essential in the regulation of cell size. The finding
that PTEN acts in the Drosophila insulin pathway, together
with previous reports that Inr, chico and PI3K affect cell size
(Bohni et al., 1999; Leevers et al., 1996), supports a pivotal
role for the insulin signaling pathway in cell-size regulation.
The conservation of this pathway raises the possibility that it
may be involved in the regulation of cell size in different
organisms. Finally, the observation that all signals from the
insulin receptor can be antagonized by either Drosophila or
human PTEN indicates that modulation of PTEN activity could
be an effective means for alleviating symptoms associated with
altered insulin signaling.
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